[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI902814A0 - Proteiner, vaccin och nukleinsyror. - Google Patents

Proteiner, vaccin och nukleinsyror.

Info

Publication number
FI902814A0
FI902814A0 FI902814A FI902814A FI902814A0 FI 902814 A0 FI902814 A0 FI 902814A0 FI 902814 A FI902814 A FI 902814A FI 902814 A FI902814 A FI 902814A FI 902814 A0 FI902814 A0 FI 902814A0
Authority
FI
Finland
Prior art keywords
protein
nukleinsyror
proteiner
vaccin
och
Prior art date
Application number
FI902814A
Other languages
English (en)
Inventor
Franz X Heinz
Christian W Mandl
Christian Kunz
Friedrich Dorner
Walter Bodemer
Gerhard Antoine
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI902814A0 publication Critical patent/FI902814A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI902814A 1989-06-06 1990-06-05 Proteiner, vaccin och nukleinsyror. FI902814A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89305708 1989-06-06

Publications (1)

Publication Number Publication Date
FI902814A0 true FI902814A0 (fi) 1990-06-05

Family

ID=8202711

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902814A FI902814A0 (fi) 1989-06-06 1990-06-05 Proteiner, vaccin och nukleinsyror.

Country Status (12)

Country Link
EP (1) EP0402116B1 (fi)
JP (1) JPH03151878A (fi)
AT (1) ATE143373T1 (fi)
CA (1) CA2018332A1 (fi)
CZ (1) CZ277921B6 (fi)
DD (1) DD297997A5 (fi)
DE (1) DE69028658T2 (fi)
FI (1) FI902814A0 (fi)
HU (1) HUT54306A (fi)
NO (1) NO902491L (fi)
SK (1) SK277781B6 (fi)
YU (1) YU109590A (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4224402A1 (de) * 1992-07-21 1994-01-27 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
FR2794865B1 (fr) 1999-06-09 2003-04-18 Pasteur Institut Methode de detection precoce des flavivirus et ses applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853693D1 (de) * 1987-03-20 1995-06-08 Immuno Ag DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
IL91304A0 (en) * 1988-08-20 1990-03-19 Us Health Recombinant vaccinia virus for prevention of disease caused by flavivirus

Also Published As

Publication number Publication date
EP0402116B1 (en) 1996-09-25
NO902491L (no) 1990-12-07
DD297997A5 (de) 1992-01-30
CZ277921B6 (en) 1993-06-16
NO902491D0 (no) 1990-06-05
JPH03151878A (ja) 1991-06-28
ATE143373T1 (de) 1996-10-15
HU903490D0 (en) 1990-10-28
DE69028658T2 (de) 1997-03-06
YU109590A (sh) 1992-07-20
HUT54306A (en) 1991-02-28
EP0402116A1 (en) 1990-12-12
SK277781B6 (en) 1995-01-05
CS9002806A2 (en) 1991-11-12
DE69028658D1 (de) 1996-10-31
CA2018332A1 (en) 1990-12-06

Similar Documents

Publication Publication Date Title
DK0587780T3 (da) Smitstof, som forårsager Mystery Swine Disease, vaccinepræparater og diagnostiske sæt
ATE54664T1 (de) Verfahren zur herstellung von 2-oxo-1,3dioxolanen.
HUP0002176A2 (hu) Vakcinákban vagy diagnosztikai vizsgálatokban alkalmazható PRRSV-peptidszekvenciákat azonosító PRRSV-antigénhelyek
ATE252640T1 (de) Verbindungen zur immunotherapie und diagnose von tuberkulose
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
PT868522E (pt) Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao
ATE77957T1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
DE69015945D1 (de) Verfahren zur Herstellung von p,p'-Biphenol.
DE68912734D1 (de) Verfahren zur Herstellung von Tetrafluoräthylen.
FI902814A0 (fi) Proteiner, vaccin och nukleinsyror.
DE69006820D1 (de) Verfahren zur Herstellung von 1,1-Dichlorotetrafluorethan.
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
DE69016857D1 (de) Verfahren zur Herstellung von NiNi-Diakyl- 1,8-Naphthalendiamin.
DE69005092D1 (de) Verfahren zur Herstellung von Dichlor-(2,2)-paracyclophan.
DE68916181D1 (de) Verfahren zur Herstellung von Polyglycidylethern.
DE59007364D1 (de) Verfahren zur Herstellung von 2,4-Dihydroxybenzophenon.
DE59005168D1 (de) Verfahren zur Herstellung von N,N-Dialkylaninlinen.
DE69200717D1 (de) Verfahren zur Herstellung von N,N-Dihydrocarbylhydroxylaminen.
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.
DE68913685D1 (de) Verfahren zur Herstellung von 2,2'-Bis-defla2-oxazolin.
DE59005849D1 (de) Verfahren zur Herstellung von Nitrilgruppen enthaltenden Copolymerisaten auf Basis von Ethylen.
CA2143187A1 (en) Anti-feline immunodeficiency virus (fiv) vaccines
DE59005235D1 (de) Verfahren zur Herstellung von 2,3-Dialkoxypropanalen.
DE69010130D1 (de) Verfahren zur Herstellung von p-Hydroxyneophyl-m-phenoxybenzylether.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: IMMUNO AKTIENGESELLSCHAFT